Syra Health Corp. Appoints New CFO and Directors
Ticker: SYRA · Form: 8-K · Filed: Jul 30, 2025 · CIK: 1922335
| Field | Detail |
|---|---|
| Company | Syra Health Corp (SYRA) |
| Form Type | 8-K |
| Filed Date | Jul 30, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, cfo-appointment
TL;DR
Syra Health just swapped out their CFO and added two board members. Big changes ahead?
AI Summary
Syra Health Corp. announced on July 28, 2025, a change in its board of directors and executive compensation arrangements. Specifically, the company elected two new directors, Mr. David L. Smith and Ms. Jennifer L. Smith, and appointed Mr. David L. Smith as the new Chief Financial Officer. These changes are effective immediately.
Why It Matters
Changes in key leadership roles like CFO and board composition can signal shifts in company strategy, financial oversight, and future direction.
Risk Assessment
Risk Level: medium — Changes in executive and board leadership can introduce uncertainty and potential shifts in strategy, impacting the company's stability and future performance.
Key Players & Entities
- Syra Health Corp. (company) — Registrant
- David L. Smith (person) — Newly elected director and Chief Financial Officer
- Jennifer L. Smith (person) — Newly elected director
- July 28, 2025 (date) — Effective date of changes
FAQ
Who are the newly elected directors and what are their backgrounds?
The filing states that Mr. David L. Smith and Ms. Jennifer L. Smith were elected as directors. Specific background details are not provided in this excerpt.
What is the effective date of these changes?
The changes, including the election of new directors and the appointment of the new CFO, are effective as of July 28, 2025.
What is the new role for David L. Smith?
Mr. David L. Smith has been appointed as the new Chief Financial Officer (CFO) of Syra Health Corp.
Are there any details on executive compensation changes?
The filing indicates that there are changes related to 'Compensatory Arrangements of Certain Officers,' but specific details of these arrangements are not included in this excerpt.
What is the company's principal executive office address?
The principal executive offices of Syra Health Corp. are located at 1119 Keystone Way N. #201, Carmel, IN 46032.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 30, 2025 by David L. Smith regarding Syra Health Corp (SYRA).